Blog
-
Delta-8 THC and Delta-9 THC: What’s the Difference?
Delta-8 THC and delta-9 THC are both types of tetrahydrocannabinol (THC), the main compounds found in the cannabis plant. They have similar chemical structures but are regulated differently and have different safety profiles. This discussion focuses on these two aspects to better understand their potential effects and risks on our patients.
-
5 Things Medical Students Should Know About Medical Cannabis
With 10+ years counseling patients on the use of medical cannabis, here are 5 tips I wish I had known earlier in my career.
-
Member Spotlight: Bria Brumfield
Q: Tell us a little bit about yourself.
A: My name is Bria N. Brumfield. I am 23 years old with a Bachelors of science in Health Science from Spelman College. I am currently receiving my Master of Science in Biotechnology & Medical Cannabis Therapy while being a full-time Clinical Research Coordinator at Lurie Children’s Hospital in Chicago, IL.
-
Introduction to Cannabinoid Medicine
Our patients are likely struggling with cannabis more than you realize. While medical and recreational legalization have been moving quickly and seem like “it’s all fun and games”, the reality is that our patients, whether using medically or recreationally, need our intervention and guidance more than ever.
-
Psychedelics: A Clinical Perspective
On Tuesday, October 22, 2024, the Association of Cannabinoid Specialists welcomed Eugene Vortsman, DO to present on Psychedelic Medicine: A Clinical Perspective.
-
Association of Cannabinoid Specialists’ Position on Medical Use of Cannabinoids as Applied to Special Groups
Association of Cannabinoid Specialists (ACS) wishes to reiterate that, to the extent that medical use of cannabis or cannabinoid medicines is available to the general public in any jurisdiction and supported by human-based scientific evidence, all patients must have access to such cannabinoid treatment when offered under the guidance of a duly-authorized medical prescriber.
-
Association of Cannabinoid Specialists’ Position on Medical Use of Cannabinoids for Prisoners and Parolees
A Response to Pending Hearing in the Case of State of West Virginia vs. Schober
-
The Endocannabinoid System and Colitis: Exploring the clinical data surrounding the use of cannabis for inflammatory bowel disease
Preclinical data supports the use of cannabinoids for gastrointestinal inflammation, but does this translate into patient outcomes?
-
Questions Patients Commonly Ask (That Doctors Should Know How to Answer)
When considering medical cannabis, patients often have numerous questions for their physicians. These questions typically revolve around safety, efficacy, legal issues, and personal concerns. Here are some of the most common questions patients are likely to ask their physicians about medical cannabis:
-
ACS Presents: A Policy Panel on Rescheduling
On September 24, 2024, the Association of Cannabinoid Specialists (www.cannaspecialists.com) hosted a paneled event surrounding the topic of policy and rescheduling, and what it means for patients and clinicians.